向日葵(300111) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was ¥51,002,844.05, a decrease of 27.11% compared to ¥69,969,920.23 in the same period last year[7] - The net profit attributable to shareholders was ¥5,760,063.44, down 41.68% from ¥9,876,347.37 year-on-year[7] - The net profit after deducting non-recurring gains and losses was -¥3,941,927.38, representing a decline of 150.18% compared to ¥7,855,605.53 in the previous year[7] - The basic earnings per share were ¥0.0051, down 42.05% from ¥0.0088 in the same period last year[7] - The weighted average return on net assets was 3.76%, a decrease of 14.10% compared to 17.86% in the previous year[7] - The company's net profit for Q1 2021 was CNY 5,760,063.44, a decrease of 41.68% compared to CNY 9,876,347.37 in Q1 2020, primarily due to a decline in sales revenue and gross margin, along with an increase in selling expenses[18] - Q1 2021 operating revenue was CNY 51,002,844.05, down 27.11% from CNY 69,969,920.23 in Q1 2020, attributed to a decrease in main business income[18] - The company reported a decrease in inventory levels, remaining stable at CNY 107,939.24[36] - The total profit for the period was CNY 3,740,236.42, down from CNY 13,925,970.97 in the previous year[44] - The total comprehensive income for the period was CNY 3,651,602.47, down from CNY 12,691,750.68 in the previous year[42] Cash Flow - The net cash flow from operating activities improved significantly to ¥7,216,802.30, a 92.06% increase from -¥38,160,258.74 in the same quarter last year[7] - The net cash flow from operating activities was CNY 7,216,802.30 in Q1 2021, a significant turnaround from -CNY 38,160,258.74 in Q1 2020, primarily due to the reversal of previously accrued liabilities[16] - The cash flow from operating activities showed a recovery trend, with a notable increase in cash inflow compared to the previous year[51] - The cash flow from investing activities was -CNY 3,394,816.39 in Q1 2021, a decrease of 103.07% compared to CNY 110,683,580.78 in Q1 2020, due to the previous year's equity transfer proceeds[16] - Total cash inflow from investment activities was ¥212,525,475.99, while cash outflow was ¥101,841,895.21, resulting in a net cash flow of ¥110,683,580.78 from investment activities[49] - The company reported a cash inflow of ¥30,197,494.44 from financing activities, but had a cash outflow of ¥110,686,427.55, leading to a net cash flow deficit of ¥80,488,933.11 from financing activities[50] Assets and Liabilities - The total assets at the end of the reporting period were ¥528,274,562.63, a decrease of 6.41% from ¥564,444,831.14 at the end of the previous year[7] - The company's cash and cash equivalents decreased from ¥225,642,535.14 to ¥201,764,383.38, representing a decline of approximately 10.6%[31] - Accounts receivable decreased from ¥64,913,744.59 to ¥43,194,809.38, a reduction of about 33.5%[31] - Total liabilities decreased to CNY 253,563,151.13 from CNY 293,385,022.11[34] - The company's total assets decreased to CNY 528,274,562.63 from CNY 564,444,831.14[34] Operational Challenges - The company faces risks from decreased market demand due to the COVID-19 pandemic, particularly affecting the export of its products[19] - The company is monitoring the impact of new pharmaceutical policies and regulations, which may increase operational costs and introduce uncertainties[20] - The company has been affected by regional drug procurement policies, which have limited the sales and promotion of its product, Lacidipine dispersible tablets, in certain areas[21] - The company is facing risks related to raw material price fluctuations, particularly for the main raw material of clarithromycin, which could impact future operating performance[22] Management and Governance - The company has implemented internal control systems to enhance quality management, including quality risk management procedures and production date management[22] - The company has successfully resolved a product liability dispute, leading to the lifting of restrictions on its bank accounts and removal from the list of dishonest entities[23] - The company is committed to monitoring industry developments and improving its operational management to mitigate risks arising from policy changes[21] - The company has maintained a focus on safety, environmental protection, and quality, continuously optimizing its management systems[22] Miscellaneous - The company received government subsidies amounting to ¥672,894.74 during the reporting period[8] - The total number of ordinary shareholders at the end of the reporting period was 96,815[10] - The company has not undergone an audit for the Q1 2021 report, indicating that the figures are unaudited[55] - The company did not apply the new leasing standards for the first quarter of 2021, which may impact future financial reporting[54]